Sequent Scientific Limited

SEQUENT

INE807F01027

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-04-26 am EDT			5-day change	1st Jan Change
125 ^INR	+0.12%		+4.78%	+9.75%

Apr. 04	Sequent Scientific's Joint Managing Director Resigns	MT
Apr. 04	Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024	CI

Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024

December 06, 2023 at 07:14 am EST

Sequent Scientific Limited announced that Mr. Krunal Shah has resigned from the position of Company Secretary & Compliance Officer of the Company due to personal reasons. He will continue in his current role till the close of business hours of February 15, 2024.

Latest news about Sequent Scientific Limited

Sequent Scientific's Joint Managing Director Resigns	Apr. 04	MT
Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024	Apr. 04	CI
Transcript : Sequent Scientific Limited, Q3 2024 Earnings Call, Feb 15, 2024	Feb. 15
Sequent Scientific Limited Announces Executive Changes	Feb. 13	CI
Sequent Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13	CI
Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024	Dec. 06	CI
Sequent Scientific Appoints CFO	Nov. 06	MT
Transcript : Sequent Scientific Limited, Q2 2024 Earnings Call, Nov 07, 2023	Nov. 06
Sequent Scientific's CFO Resigns	23-10-17	MT
Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer	23-10-16	CI
Transcript : Sequent Scientific Limited, Q1 2024 Earnings Call, Aug 11, 2023	23-08-10
Sequent Scientific Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Sequent Scientific Discontinues Manufacturing Operations at Tarapur Unit in India	23-07-16	MT
Sequent Scientific Limited Announces Discontinuation of Manufacturing Operations At Tarapur, Maharashtra	23-07-14	CI
Transcript : Sequent Scientific Limited, Q4 2023 Earnings Call, May 24, 2023	23-05-23
Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-23	CI
INDIA STOCKS-Indian shares fall on rate fears after Powell reiterates hawkish message	23-03-08	RE
SeQuent Scientific Terminates Agreement to Acquire Tineta Pharma	23-03-08	MT
Indian shares set for muted start as Powell reiterates hawkish message	23-03-08	RE
Sequent Scientific Limited cancelled the acquisition of Tineta Pharma Private Limited from group of shareholders.	23-03-07	CI
Transcript : Sequent Scientific Limited, Q3 2023 Earnings Call, Feb 15, 2023	23-02-14
Sequent Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Sequent Scientific Limited Announces Resignation of Rahul Mukim as Director	22-12-07	CI
Transcript : Sequent Scientific Limited, Q2 2023 Earnings Call, Nov 08, 2022	22-11-08
Sequent Scientific Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-07	CI

Chart Sequent Scientific Limited

Duration

Period

More charts

Company Profile

SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.

Sector

Pharmaceuticals

Calendar

2024-05-29 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SEQUENT SCIENTIFIC LIMITED	+9.75%	372M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals